<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HE2943789F7DD495F8B944586C8AB0DA5" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 HR 3924 IH: Streamlining Part D Appeals Process Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2019-07-23</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">116th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 3924</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20190723">July 23, 2019</action-date><action-desc><sponsor name-id="S001201">Mr. Suozzi</sponsor> (for himself and <cosponsor name-id="R000585">Mr. Reed</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To provide for the treatment of a pharmacy counter refusal as a coverage determination under
			 Medicare part D.</official-title></form>
	<legis-body id="H7BEA6795599C4840ABC93C60D078D22C" style="OLC">
 <section id="H05FFC31AADFA43EDA771BCFC27DAC4A6" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Streamlining Part D Appeals Process Act</short-title></quote>.</text> </section><section id="H675B2B120DE94ED9A9B01D9F8FD0D12E"><enum>2.</enum><header>Providing for the treatment of a pharmacy counter refusal as a coverage determination under Medicare part D</header><text display-inline="no-display-inline">Section 1860D–4(g) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-104">42 U.S.C. 1395w–104(g)</external-xref>) is amended by adding at the end the following new paragraph:</text>
			<quoted-block display-inline="no-display-inline" id="HDBCA05266ED74D998486A852479C107C" style="OLC">
 <paragraph id="H2E4F70DDEC9F47E7A7CEE8D4C7E13AC6"><enum>(3)</enum><header>Treatment of pharmacy counter refusal as coverage determination</header><text>For plan years beginning on or after January 1, 2020, the refusal by a pharmacy to fill a prescription for a covered part D drug under a prescription drug plan shall be treated as a coverage determination subject to reconsideration and appeal pursuant to this subsection and subsection (h).</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
		</section></legis-body></bill>


